Sprague Suzanne 4

What Happened
Suzanne Sprague, COO & Global Head of Clearing at CME Group (CME), received a performance-based award of 5,504 shares on 2026-03-15 at an imputed price of $311.40 per share (value ≈ $1,713,946). To satisfy tax-withholding obligations, she surrendered 2,439 shares (≈ $759,505) and an additional 76 shares (≈ $23,666), a total of 2,515 shares surrendered (≈ $783,171). Net shares delivered to Ms. Sprague from this vesting event were 2,989 shares.

Key Details

• Transaction date(s): 2026-03-15 (filed on 2026-03-17) — filing appears within the standard two-business-day Form 4 window.
• Award: 5,504 shares granted/acquired at $311.40 per share (total ≈ $1,713,946). (Code A = Award/Grant)
• Withholding disposals: 2,439 shares and 76 shares surrendered at $311.40 per share (total surrendered ≈ $783,171). (Code F = Tax withholding)
• Net shares retained from this vesting: 2,989 shares.
• Footnotes: F1 — vesting of 2022 performance shares under CME’s Omnibus Stock Plan, payout based on three‑year TSR vs. S&P 500 (1/1/2023–12/31/2025). F2/F3 — shares surrendered to the company to satisfy tax withholding on the performance award and on restricted stock vesting.

Context
This was a compensation-related vesting event (not an open-market purchase or sale). Awards and routine tax-withholding surrenders are common executive compensation mechanics and do not necessarily signal the insider’s trading view. Transaction codes: A = award/grant (acquisition), F = surrender/disposition to cover taxes.